RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
  Bladder
  Blood
  Bone Cancer
  Brain
  Breast Cancer
  Carcinogens
  Cervical Cancer
  Colon
  Endometrial
  Esophageal
  Gastric Cancer
  Liver Cancer
  Lung
  Nerve Tissue
  Ovarian Cancer
  Pancreatic Cancer
  Prostate Cancer
  Rectal Cancer
  Renal Cell Carcinoma
  Risk Factors
  Skin
  Testicular Cancer
  Therapy
  Thyroid
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Prostate Cancer Channel

subscribe to Prostate Cancer newsletter
Latest Research : Cancer : Prostate Cancer

   EMAIL   |   PRINT
Pomegranate juice could kill cancer cells

Jul 1, 2006 - 2:57:00 PM , Reviewed by: Priya Saxena
'There are many substances in pomegranate juice that may be prompting this response,'

 
[RxPG] Drinking an eight ounce glass of pomegranate juice daily could slow the progress of prostate cancer, minimise cell damage and could also kill cancer cells, finds a new study.

Researchers led by Allan Pantuck at the University of California, Los Angeles, studied 50 men who had undergone surgery or radiation treatment for prostate cancer - but had shown signs that the disease was rapidly returning.

The presence of prostate cancer cells is monitored by measuring levels of a chemical they produce called prostate-specific antigen (PSA). The researchers measured how long it took for PSA levels to double in individual patients - a short doubling time indicates that the cancer is progressing quickly.

The average doubling time is about 15 months, but in patients who drank pomegranate juice, this increased to an average of 54 months.

Some patients continued to show suppressed PSA levels after more than three years, even though they were receiving no treatment apart from drinking pomegranate juice, said Pantuck.

The researchers added that the effect may be so large that it may help older men outlive the disease.

'There are many substances in pomegranate juice that may be prompting this response,' said Pantuck.

'We are hoping we may be able to prevent or delay the need for other therapies usually used in this population such as hormone treatment or chemotherapy, both of which bring with them harmful side effects,' added Pantuck.

Pomegranates have been linked to many health benefits. It contains a cocktail of chemicals including isoflavones, which are believed to play a role in cancer cell death.

Previous research, conducted through tests on mice, has indicated that pomegranate juice could have a beneficial effect on prostate cancer.



Publication: Indo Asian News Service

Advertise in this space for $10 per month. Contact us today.


Related Prostate Cancer News
Abiraterone has been approved for men with metastatic prostate cancer that is no longer responsive to therapy with hormones and docetaxel
Virus associated with prostate cancer tumors and chronic fatigue syndrome unlikely to be the cause
Acupuncture helps with side effects of prostate cancer treatment
Surgery superior to drug therapy for symptoms of benign prostatic hypertrophy
Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer
Inhibition of TNF-receptor associated protein-1possible treatment for prostatic cancer
Oncologists present test to predict survival in castration-resistant prostate cancer patients
PSA levels appear to be predictive of three year prostate cancer risk in African-American men
Survey on PSA screening in young men
New, noninvasive prostate cancer test beats PSA in detecting prostate cancer

Subscribe to Prostate Cancer Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)